Cargando…

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

BACKGROUND: The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) checklist consists of 20 items to report for published tumor marker prognostic studies. It was developed to address widespread deficiencies in the reporting of such studies. In this paper we expand on the REMARK c...

Descripción completa

Detalles Bibliográficos
Autores principales: Altman, Douglas G, McShane, Lisa M, Sauerbrei, Willi, Taube, Sheila E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362748/
https://www.ncbi.nlm.nih.gov/pubmed/22642691
http://dx.doi.org/10.1186/1741-7015-10-51
_version_ 1782234252122783744
author Altman, Douglas G
McShane, Lisa M
Sauerbrei, Willi
Taube, Sheila E
author_facet Altman, Douglas G
McShane, Lisa M
Sauerbrei, Willi
Taube, Sheila E
author_sort Altman, Douglas G
collection PubMed
description BACKGROUND: The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) checklist consists of 20 items to report for published tumor marker prognostic studies. It was developed to address widespread deficiencies in the reporting of such studies. In this paper we expand on the REMARK checklist to enhance its use and effectiveness through better understanding of the intent of each item and why the information is important to report. METHODS: REMARK recommends including a transparent and full description of research goals and hypotheses, subject selection, specimen and assay considerations, marker measurement methods, statistical design and analysis, and study results. Each checklist item is explained and accompanied by published examples of good reporting, and relevant empirical evidence of the quality of reporting. We give prominence to discussion of the 'REMARK profile', a suggested tabular format for summarizing key study details. SUMMARY: The paper provides a comprehensive overview to educate on good reporting and provide a valuable reference for the many issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general. To encourage dissemination of the Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration, this article has also been published in PLoS Medicine.
format Online
Article
Text
id pubmed-3362748
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33627482012-05-31 Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration Altman, Douglas G McShane, Lisa M Sauerbrei, Willi Taube, Sheila E BMC Med Correspondence BACKGROUND: The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) checklist consists of 20 items to report for published tumor marker prognostic studies. It was developed to address widespread deficiencies in the reporting of such studies. In this paper we expand on the REMARK checklist to enhance its use and effectiveness through better understanding of the intent of each item and why the information is important to report. METHODS: REMARK recommends including a transparent and full description of research goals and hypotheses, subject selection, specimen and assay considerations, marker measurement methods, statistical design and analysis, and study results. Each checklist item is explained and accompanied by published examples of good reporting, and relevant empirical evidence of the quality of reporting. We give prominence to discussion of the 'REMARK profile', a suggested tabular format for summarizing key study details. SUMMARY: The paper provides a comprehensive overview to educate on good reporting and provide a valuable reference for the many issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general. To encourage dissemination of the Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration, this article has also been published in PLoS Medicine. BioMed Central 2012-05-29 /pmc/articles/PMC3362748/ /pubmed/22642691 http://dx.doi.org/10.1186/1741-7015-10-51 Text en Copyright ©2012 Altman et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Altman, Douglas G
McShane, Lisa M
Sauerbrei, Willi
Taube, Sheila E
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
title Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
title_full Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
title_fullStr Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
title_full_unstemmed Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
title_short Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
title_sort reporting recommendations for tumor marker prognostic studies (remark): explanation and elaboration
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362748/
https://www.ncbi.nlm.nih.gov/pubmed/22642691
http://dx.doi.org/10.1186/1741-7015-10-51
work_keys_str_mv AT altmandouglasg reportingrecommendationsfortumormarkerprognosticstudiesremarkexplanationandelaboration
AT mcshanelisam reportingrecommendationsfortumormarkerprognosticstudiesremarkexplanationandelaboration
AT sauerbreiwilli reportingrecommendationsfortumormarkerprognosticstudiesremarkexplanationandelaboration
AT taubesheilae reportingrecommendationsfortumormarkerprognosticstudiesremarkexplanationandelaboration